16 OUTCOMES IN PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROME RECEIVING EX-VIVO T-CELL DEPLETED OR UNMODIFIED ALLOGRAFTS: COMPARISON OF RESULTS AT TWO INSTITUTIONS. (April 2015) - Tamari, R.; Oran, B.; Hilden, P.; Papadopoulos, E.; Kongtim, P.; Rondon, G.; Jakubowski, A.; Anderssson, B.; Devlin, S.; Ahmed, S.; Young, J.; Popat, U.; et al.